Original Article
11 November 2026 by edra
Background. Therapeutic patient education (TPE) is recommended in atopic dermatitis (AD), yet the comparative feasibility of different educational formats remains poorly defined. We compared knowledge level, feasibility and clinical outcomes across three take-home formats added to standardized verbal counselling. Methods. In this evaluator-blinded, parallel-group randomized controlled trial, patients aged 0–75 years with AD were allocated […]
Read more »
Background. Sensitization to Dermatophagoides pteronyssinus molecular allergens (MA) Der p1, Der p2 and Der p23 was previously only detectable via in vitro specific IgE (sIgE). As these allergens are now available for skin prick testing (SPT), we aimed to compare the frequency and concordance of MA sensitization in vitro and in vivo. Methods. We included […]
Letter to the Editor
10 November 2026 by edra
Background. Cholinergic urticaria (CholU) is characterized by itchy wheals induced by physical exercise, yet validated tools for diagnosis and severity assessment remain limited. The Pulse-Controlled Ergometry (PCE) test and Cholinergic Urticaria Severity Index (CholUSI) were only evaluated in a limited number of patients. We aimed to evaluate the diagnostic value of the PCE test and […]
Background. Epinephrine autoinjectors (EAIs) are the first-line treatment for anaphylaxis, and they are recommended in guidelines on anaphylaxis management. Despite these clear indications, EAIs remain largely underused, with an alarming rate of incorrect administration. This study evaluates patients’ ability of self-administration of EAIs, the most common mistakes made, and patients’ availability of their own device. […]
Background. Venom immunotherapy (VIT) is the only disease-modifying treatment for Hymenoptera venom allergy, and its effectiveness relies on accurate identification of the venom responsible for primary sensitization. In patients with clinically presumed Vespa crabro stings, this is challenging because extensive IgE cross-reactivity among Vespid venoms and limitations of current diagnostic reagents complicate interpretation of routine […]
20 October 2026 by edra
Background. Growing evidence suggests that cross-reactivity between penicillins and cephalosporins is mainly driven by R1 side-chain similarity rather than the beta-lactam core. Although cefuroxime, ceftriaxone and cefixime appear to have a low cross-reactivity risk, their use in patients with confirmed penicillin hypersensitivity (HS) remains inconsistent. We aimed to assess the prevalence of HS to cephalosporins […]
Background. Chronic spontaneous urticaria (CSU) is a common, challenging condition, usually impairs patients’ quality of life. While current medications are mainly symptom-based, many people still suffer. There is limited and inconclusive evidence suggesting a possible role of gluten sensitivity in CSU, and current international guidelines do not recommend a gluten-free diet as a standard therapeutic […]
19 October 2026 by edra
Background. Multiplex diagnostics may identify IgE reactivity without a corresponding phenotype documented at testing. This record-level discordance can reflect incomplete history, limited exposure, cross-recognition, or broader atopy and is not equivalent to asymptomatic sensitisation. We described concordance across six allergen groups and routine-care reassessment of selected Pru p 3/nsLTP and Hymenoptera findings. Methods. We retrospectively […]